Astria Therapeutics, Inc. (ATXS) Misses Q1 EPS by 13c

Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q1 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Goldman, BofA vie to manage Anthropic employee wealth post-IPO - report
• Northrop Grumman wins two U.S. defense contracts worth $38.7m